w3m is a terminal-based browser that works well for distraction-free reading but falls short as a modern browser replacement.

Port Tampa Bay plans to expand our Dark Sky efforts as our lines of business grow and require new berthing space. Port Tampa Bay’s two dredge spoil islands are home to significant populations of ...

Apple's Terminal app is getting a visual refresh in macOS Tahoe, and it's the first notable design update since the command-line tool debuted. The updated Terminal will support 24-bit color and ...

The start of the 2025 college football season is months away, but one team has already been eliminated from playing in the postseason. The Akron football team will be ineligible this season because of ...

The $1.7 billion Pittsburgh International Airport modernization project is hundreds of millions more than initially planned. Inflation isn’t solely to blame for the rising cost of the project, ...

Apple is going all out with promotions for the popular Severance Apple TV+ show today, and as of right now, you'll find a new "Lumon Terminal Pro" listed on Apple's Mac site. The Lumon Terminal Pro is ...

Java Development Kit (JDK) 24 is now available as a production release. A short-term support release of standard Java, JDK 24 will receive only six months of Premier-level support from Oracle, ...

Mac Doyle was quite familiar with the CEFCU Arena court he played on Monday night. The Benet senior guard’s mom, Cara, coached the St. Ignatius girls team to second place in Class 3A there two nights ...

I know you had hoped that in this off-season there would be minimal football news. Maybe some transfer portal news. Potentially television deals or coaching changes. Of course, the usual NFL combine ...

As per the terms of the agreement, OS Therapies will pay an aggregate purchase price of $8 million. This will include $0.5 million in cash and $7.5 million worth of OS Therapies’ common shares. The ...

NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it has ...